Literature DB >> 6213714

Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus.

M Horita, H Suzuki, T Onodera, F Ginsberg-Fellner, A S Fauci, A L Notkins.   

Abstract

Patients with insulin-dependent diabetes mellitus (IDDM) have autoantibodies that react with cells in the islets of Langerhans. To determine whether these patients suffer from a more generalized immunoregulatory disorder, the ratio of phenotypic helper to suppressor cells was evaluated by specific monoclonal antibodies. Our experiments showed that the helper/suppressor cell ratio was significantly increased in patients with IDDM of less of 2 mo duration and then gradually returned to normal. Despite the alteration in the helper/suppressor cell ratio, there was no evidence for polyclonal activation as measured by the number of immunoglobulin-secreting plaque-forming cells in the peripheral blood. There was, however, a significant increase in the number of spontaneous plaque-forming cells in patients suffering from both IDDM and Hashimoto's thyroiditis (HT). Nonetheless, immunoglobulin production after stimulation with pokeweed mitogen was not different in diabetics with or without HT when compared to normal controls. These findings suggest that subtle changes in the immunoregulatory system occur during the early stages of IDDM.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213714

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.

Authors:  A Lernmark; H Bärmeier; S Dube; W Hagopian; A E Karlsen; H Markholst; C Wilson; R Wassmuth
Journal:  West J Med       Date:  1990-11

Review 2.  Lymphocyte subpopulations.

Authors:  R J Powell; J S Jenkins
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

3.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 4.  Molecular biology of type 1 (insulin-dependent) diabetes mellitus.

Authors:  A Lernmark
Journal:  Diabetologia       Date:  1985-04       Impact factor: 10.122

Review 5.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 6.  Immunological concepts in insulin-dependent (type I) diabetes mellitus.

Authors:  A Etzioni
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

7.  In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.

Authors:  M Mizutani; M El-Fotoh; M Mori; K Ono; K Doi; A Awaya; Y Matsumoto; Y Matsumoto; T Onodera
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice.

Authors:  T Hayashi; K Yoshinaka; K Hasegawa; K Maeda; T Onodera
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

9.  Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena.

Authors:  K C Herold; A Huen; L Gould; H Traisman; A H Rubenstein
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

10.  Lymphocyte function in human bone marrow. II. Characterization of an interleukin 2-sensitive T precursor-cell population.

Authors:  H M Dosch; C J Ledgley; D White; P Lam; G B Mills
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.